This unique enduring accredited activity, targeted for US-based allergists, otolaryngologists, and pulmonologists, will focus on improving clinicians’ knowledge and competence knowledge, competence in the treatment of CRSwNP with novel biologic therapies. As a result of this educational activity, learners should be better able to: 1. Identify key considerations for initiating a biologic therapy in patients with CRSwNP; 2. Discuss the clinical impact of the latest data for novel approved biologics in CRSwNP; and 3. Apply best practice approaches for management of biologics in patients with CRSwNP. Insights from the learner target audience were collected and used to help define the topics discussed making this a practical, clinically relevant educational opportunity. Content is presented via 5 video-based sessions in a fast-paced microburst learning format. Features include downloadable slides and podcast.
- Provider:Answers in CME Inc. (AiCME)
- Activity Link: https://www.answersincme.com/YWD
- Start Date: 2024-11-26 06:00:00
- End Date: 2024-11-26 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.5 hours
- Commercial Support: Source: Regeneron Pharmaceuticals, Inc. - Amount: 189851.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Competence, Learner Knowledge
- Provider Ship: Directly Provided
- Registration: Open to all